Role of the Blood-Brain Barrier in Stress Resilience: Investigating New Pathways Towards Pharmacological Augmentation of Stress Resilience

NANot yet recruitingINTERVENTIONAL
Enrollment

122

Participants

Timeline

Start Date

June 30, 2025

Primary Completion Date

February 28, 2027

Study Completion Date

February 28, 2027

Conditions
Stress ResilienceBlood-Brain Barrier IntegrityMental Health
Interventions
DRUG

Metformin

The Metformin intervention will be self-administred capsules, taken during a 12-week period: Four weeks of dose increase; first and second week 500 mg once daily, third and fourth week 500mg twice daily. Full-dose administration (850 mg twice daily) for eight weeks.

DRUG

Placebo

This intervention will be self-administered placebo capsules

Trial Locations (3)

55131

Universitätsmedizin der Johannes Gutenberg-Universität Mainz (UM), Mainz

00-927

University of Warsaw, Warsaw

CH-8032

University Zurich (UZH), Zurich

All Listed Sponsors
collaborator

University of Latvia

OTHER

collaborator

University of Zurich

OTHER

collaborator

Johannes Gutenberg University Mainz

OTHER

collaborator

University of Warsaw

OTHER

lead

Leibniz-Institut für Resilienzforschung (LIR) gGmbH

OTHER

NCT06965868 - Role of the Blood-Brain Barrier in Stress Resilience: Investigating New Pathways Towards Pharmacological Augmentation of Stress Resilience | Biotech Hunter | Biotech Hunter